| Enzo |
BML-P235-0001 |
ADAM substrate (fluorogenic)
|
1mg |
|
|
| Enzo |
BML-P236-0025 |
Met-AMC (fluorogenic substrate)
|
25mg |
|
|
| Enzo |
BML-P234-0001 |
Enterostatin (human)
|
1mg |
|
|
| Enzo |
BML-P234-0005 |
Enterostatin (human)
|
5mg |
|
|
| Enzo |
BML-P232-0001 |
SAMS peptide (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P233-0001 |
SAMS peptide (phosphorylated) (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P230-0100 |
Leu-pNA
|
100mg |
|
|
| Enzo |
BML-P231-0001 |
SAMS peptide
|
1mg |
|
|
| Enzo |
BML-P229-0010 |
Z-LR-AMC
|
10mg |
|
|
| Enzo |
BML-P227-0001 |
Mca-RPPGFSAFK(Dnp)
|
1mg |
|
|
| Enzo |
BML-P228-0100 |
TACE substrate II (fluorogenic)
|
100µg |
|
|
| Enzo |
BML-P226-0001 |
IKK substrate
|
1mg |
|
|
| Enzo |
BML-P225-0001 |
R18 peptide (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P224-0005 |
MeOSuc-AAPV-AMC
|
5mg |
|
|
| Enzo |
BML-P219-0500 |
PKC zeta (113-125) (myristoylated)
|
0.5mg |
|
|
| Enzo |
BML-P216-0001 |
Abl kinase substrate
|
1mg |
|
|
| Enzo |
BML-P217-0001 |
Lyn & Syk kinase substrate
|
1mg |
|
|
| Enzo |
BML-P215-0001 |
Fyn kinase substrate
|
1mg |
|
|
| Enzo |
BML-P214-0001 |
R18 peptide
|
1mg |
|
|
| Enzo |
BML-P213-0005 |
MeOSuc-AAPV-pNA
|
5mg |
|
|
| Enzo |
BML-P212-0500 |
AIP (myristoylated)
|
0.5mg |
|
|
| Enzo |
BML-P210-0500 |
PKI (14-22) amide (myristoylated)
|
0.5mg |
|
|
| Enzo |
BML-P211-0001 |
AIP
|
1mg |
|
|
| Enzo |
BML-P206-0001 |
Protein kinase C (19-31)
|
1mg |
|
|
| Enzo |
BML-P207-0500 |
EGF receptor (651-658) (myristoylated)
|
0.5mg |
|
|
| Enzo |
BML-P208-0001 |
PKG inhibitor
|
1mg |
|
|
| Enzo |
BML-P209-0001 |
MLCK (342-352) amide
|
1mg |
|
|
| Enzo |
BML-P204-0001 |
PKI (6-22) amide
|
1mg |
|
|
| Enzo |
BML-P205-0500 |
Protein kinase C (20-28) (myristoylated)
|
0.5mg |
|
|
| Enzo |
BML-P203-0500 |
PKI (5-24)
|
0.5mg |
|
|
| Enzo |
BML-P202-0500 |
[Ala286] CaM kinase 2 (281-302)
|
0.5mg |
|
|
| Enzo |
BML-P201-0500 |
CaM kinase 2 (281-309)
|
0.5mg |
|
|
| Enzo |
BML-P199-0010 |
Z-VVR-AMC
|
10mg |
|
|
| Enzo |
BML-P200-0500 |
CaM kinase 2 (290-309)
|
0.5mg |
|
|
| Enzo |
BML-P197-0001 |
Src substrate
|
1mg |
|
|
| Enzo |
BML-P198-2500 |
p53 (368-386)
|
2.5mg |
|
|
| Enzo |
BML-P196-0001 |
MAPKAPK2 substrate
|
1mg |
|
|
| Enzo |
BML-P195-0001 |
CREBtide
|
1mg |
|
|
| Enzo |
BML-P191-0001 |
Crosstide (biotinylated)
|
1mg |
|
|
| Enzo |
BML-P193-0001 |
GSK 3 substrate II
|
1mg |
|
|
| Enzo |
BML-P194-0001 |
PAK4 & Akt substrate
|
1mg |
|
|
| Enzo |
BML-P189-0005 |
GP-AMC
|
5mg |
|
|
| Enzo |
BML-P188-0025 |
GP-pNA
|
25mg |
|
|
| Enzo |
BML-P163-0001 |
Mca-APK(Dnp)
|
1mg |
|
|
| Enzo |
BML-P164-0001 |
[pThr183, pTyr185] MAP kinase (177-189)
|
1mg |
|
|
| Enzo |
BML-P165-0001 |
Z-AAD-CMK
|
1mg |
|
|
| Enzo |
BML-P162-0001 |
Abz-SDK(Dnp)-P
|
1mg |
|
|
| Enzo |
BML-P158-0001 |
Chk 1 & 2 substrate
|
1mg |
|
|
| Enzo |
BML-P160-0500 |
[pSer95, Ala97] RII (81-99)
|
0.5mg |
|
|
| Enzo |
BML-P161-0001 |
Abz-FRK(Dnp)-P
|
1mg |
|
|